Please assess the completion status of the following clinical trial:

Trial Title: Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with endometriosis-associated pelvic pain and/or dysmenorrhea.~* Patients for whom the decision to initiate treatment with YazFlex is made as per physician's clinical practice.~Exclusion Criteria:~- Patients participating in an investigational program with interventions outside of routine clinical practice.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- BAY86-5300_YAZ-Flex (Type: None): Patients with endometriosis-associated pelvic pain or dysmenorrhea

Based on this trial design, predict the completion outcome and termination type (if applicable).